MX2009011817A - Formulaciones de aminoacido n-halogenado que contienen acido alifatico. - Google Patents

Formulaciones de aminoacido n-halogenado que contienen acido alifatico.

Info

Publication number
MX2009011817A
MX2009011817A MX2009011817A MX2009011817A MX2009011817A MX 2009011817 A MX2009011817 A MX 2009011817A MX 2009011817 A MX2009011817 A MX 2009011817A MX 2009011817 A MX2009011817 A MX 2009011817A MX 2009011817 A MX2009011817 A MX 2009011817A
Authority
MX
Mexico
Prior art keywords
amino acid
halogenated amino
formulations
acid
aliphatic acid
Prior art date
Application number
MX2009011817A
Other languages
English (en)
Spanish (es)
Inventor
Masood A Chowhan
Wesley Wehsin Han
L Wayne Schneider
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of MX2009011817A publication Critical patent/MX2009011817A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Eyeglasses (AREA)
MX2009011817A 2007-05-01 2008-04-30 Formulaciones de aminoacido n-halogenado que contienen acido alifatico. MX2009011817A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91527107P 2007-05-01 2007-05-01
PCT/US2008/061950 WO2008134692A1 (en) 2007-05-01 2008-04-30 Aliphatic acid-containing n-halogenated amino acid formulations

Publications (1)

Publication Number Publication Date
MX2009011817A true MX2009011817A (es) 2009-11-13

Family

ID=39616420

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011817A MX2009011817A (es) 2007-05-01 2008-04-30 Formulaciones de aminoacido n-halogenado que contienen acido alifatico.

Country Status (17)

Country Link
US (2) US20080275126A1 (enExample)
EP (1) EP2139520B1 (enExample)
JP (2) JP2010526084A (enExample)
KR (1) KR20100017156A (enExample)
CN (1) CN101678105A (enExample)
AR (1) AR066371A1 (enExample)
AU (1) AU2008245460B2 (enExample)
BR (1) BRPI0811073A2 (enExample)
CA (1) CA2684101A1 (enExample)
CL (1) CL2008001283A1 (enExample)
ES (1) ES2432408T3 (enExample)
MX (1) MX2009011817A (enExample)
RU (1) RU2009144291A (enExample)
TW (1) TW200902092A (enExample)
UY (1) UY31057A1 (enExample)
WO (1) WO2008134692A1 (enExample)
ZA (1) ZA200907052B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2265267B1 (en) * 2008-04-10 2016-09-21 Waldemar Gottardi Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
WO2009127924A1 (en) * 2008-04-15 2009-10-22 Waldemar Gottardi Compositions and devices for antisepsis and anticoagulation
CN113729039A (zh) * 2021-08-27 2021-12-03 上海罗克环控节能科技股份有限公司 一种绿色环保消毒液及其制造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027965B2 (ja) * 1980-02-23 1985-07-02 東洋コンタクトレンズ株式会社 コンタクトレンズに付着した汚れの除去方法
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
AU3070395A (en) * 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6387427B1 (en) * 2000-09-28 2002-05-14 Nestec S.A. Method of preservation of a food product
WO2003061566A2 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
PL1656095T3 (pl) * 2003-08-18 2014-04-30 Novabay Pharmaceuticals Inc N,n-dwuchlorowcowane kwasy aminowe i pochodne
TWI386201B (zh) * 2005-01-25 2013-02-21 Novabay Pharmaceuticals Inc Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法
TWI432231B (zh) * 2005-10-06 2014-04-01 Novabay Pharmaceuticals Inc 使用ｎ-鹵化胺基酸於預防包括泌尿道感染（ｕｔｉ）之細菌性與真菌性感染的系統與方法

Also Published As

Publication number Publication date
CA2684101A1 (en) 2008-11-06
BRPI0811073A2 (pt) 2014-12-09
UY31057A1 (es) 2008-10-31
KR20100017156A (ko) 2010-02-16
TW200902092A (en) 2009-01-16
CN101678105A (zh) 2010-03-24
RU2009144291A (ru) 2011-06-10
JP2010526084A (ja) 2010-07-29
WO2008134692A1 (en) 2008-11-06
ES2432408T3 (es) 2013-12-03
EP2139520B1 (en) 2013-08-21
ZA200907052B (en) 2010-12-29
EP2139520A1 (en) 2010-01-06
AR066371A1 (es) 2009-08-12
JP2014098037A (ja) 2014-05-29
US20080275126A1 (en) 2008-11-06
AU2008245460B2 (en) 2013-08-22
CL2008001283A1 (es) 2009-01-16
US20110060044A1 (en) 2011-03-10
AU2008245460A1 (en) 2008-11-06

Similar Documents

Publication Publication Date Title
EP2349279A4 (en) MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF
CY1117547T1 (el) Ενωση πυραζολοκινολινης
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
PH12013500775A1 (en) Synergistic activity of peracetic acid and at least one sar inducer for the control of pathogens in and onto growing plants
PH12012500903A1 (en) N1 - pyrazolospiroketone acetyl-coa carboxylase inhibitors
MX336187B (es) Metodo para tratar el mal de parkinson.
MX2021001169A (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acético, composiciones, y usos de las mismas.
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
WO2010111640A3 (en) Anti-influenza formulations and methods
NZ597510A (en) NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
PH12013501688A1 (en) Treatment of amyotrophic lateral sclerosis using umbilical derived cells
WO2011126250A3 (ko) Pde5 억제제를 함유하는 피부 주름 개선용 조성물
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
EP4302825A3 (en) Pharmaceutical compositions for treatment of inappetence
MX2011009482A (es) Metodo o sistema que usa biomarcadores para el monitoreo de un tratamiento.
MX2009011819A (es) Formulaciones de aminoacido n-halogenado.
EA201171431A1 (ru) Применение комбинации d-аспарагиновой и l-аспарагиновой кислот или их солей для лечения мужского бесплодия
MX2009011817A (es) Formulaciones de aminoacido n-halogenado que contienen acido alifatico.
MX2009011818A (es) Formulaciones de aminoacido n-halogenado con compuestos anti-inflamatorios.
WO2011026577A3 (de) Zubereitungen mit wasserunlöslichen polymeren aminen zur verminderung von körpergeruch
CL2008001280A1 (es) Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano.
WO2014006571A3 (en) Extended-release pharmaceutical dosage forms of carbidopa and levodopa and processes of preparation thereof
ECSP12012332A (es) Asociación de inhibidores de la xantina oxidasa y la instatina y su uso
WO2011018739A3 (en) Use of a composition for treatment and/or prophylaxis of plants and relative composition

Legal Events

Date Code Title Description
FA Abandonment or withdrawal